Luoma JB

Portland Institute for Psychedelic Science, Portland, Oregon.

14 preprints · 11 papers · ORCID

PreprintPsilocybin

Oregon’s State-Regulated Psilocybin Services: Early Real-World Safety Signals

Luoma JB, Chwyl C, Jarlais DD +6

Europe PMC2026
PreprintMDMA

Therapeutic Alliance and Perceived Closeness in MDMA-Assisted Therapy for Social Anxiety Disorder

Diehl JM, Chwyl C, Kennedy L +2

Europe PMC2026
ArticlePsilocybin

Oregon's state-regulated psilocybin services: Early real-world safety signals.

Luoma JB, Chwyl C, Des Jarlais D +6

Europe PMC2026
ArticlePsilocybin

Safety and Mental Health Outcomes of Oregon State-Regulated Psilocybin Services.

Korthuis PT, Cook RR, Gregoire D +8

Europe PMC2026
PreprintMDMA

MDMA-Assisted Therapy for Social Anxiety Disorder: A Randomized, Open-label, Wait-list Controlled Trial

Luoma JB, Lear MK, Pilecki B +9

Europe PMC2026
ArticlePsychedelics

Prevalence and predictors of sexual and physical violence during psychedelic use in a US population-based study.

Chwyl C, Ladka MS, Black JC +4

Europe PMC2026
PreprintPsilocybin

Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs

Luoma JB, Hoffman K, Wilson-Poe A +12

Europe PMC2026
PreprintPsilocybin

Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives

Chwyl C, Bazinet A, Wilson-Poe A +5

Europe PMC2026
PreprintPsilocybin

Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives

Chwyl C, Bazinet A, Wilson-Poe A +5

Europe PMC2026
ArticlePsilocybin

Mindset over molecule: comparing self-transcendent and mystical experiences across recreational psilocybin, MDMA, and cannabis use.

Chwyl C, Spata A, Lucas W +1

Europe PMC2026
PreprintMDMA

Practical Guidelines for Supportive Touch in Psychedelic-Assisted and MDMA-Assisted Therapy: A Model for Practitioners and Researchers

Luoma JB, Lejeune J, Pilecki B +2

Europe PMC2026
PreprintPsilocybin

Mindset Over Molecule: Comparing Self-Transcendent and Mystical Experiences Across Recreational Psilocybin, MDMA, and Cannabis Use

Chwyl C, Spata A, Lucas W +1

Europe PMC2025
PreprintMDMA

MDMA-assisted Acceptance and Commitment Therapy for Posttraumatic Stress Disorder: Rationale for a New Approach

Herbert M, Blanco B, Perivoliotis D +4

Europe PMC2025
PreprintMDMA

Utilizing In Vivo and Imaginal Exposure in the Context of MDMA-Assisted Therapy for Social Anxiety Disorder: A Case Report

Luoma JB, Lear MK, Yi K +1

Europe PMC2025
ArticlePsilocybin

Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.

Chwyl C, Wilson-Poe AR, Hoffman KA +6

Europe PMC2026
PreprintMDMA

Beyond the Journey: A Qualitative Analysis of Therapists’ Perspectives on Psychedelic Integration Challenges

Chwyl C, Elvenes OS, Kleven ASR +4

Europe PMC2025
ArticlePsilocybin

Oregon's Emerging Psilocybin Services Workforce: A Survey of the First Legal Psilocybin Facilitators and Their Training Programs.

Luoma JB, Hoffman K, Wilson-Poe AR +12

Europe PMC2026
PreprintPsilocybin

Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts

Luoma JB, Wilson-Poe A, Pertl K +5

Europe PMC2024
ArticlePsilocybin

Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study.

Korthuis PT, Hoffman K, Wilson-Poe AR +10

Europe PMC2024
ArticlePsilocybin

Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.

Yaden DB, Earp D, Graziosi M +3

Europe PMC2022
ArticleAyahuasca

Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca.

Agin-Liebes G, Zeifman R, Luoma JB +3

Europe PMC2022
ArticlePsychedelics

Ethical and legal issues in psychedelic harm reduction and integration therapy.

Pilecki B, Luoma JB, Bathje GJ +2

Europe PMC2021
PreprintPsilocybin

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Luoma JB, Chwyl C, Bathje G +2

Europe PMC2020
PreprintPsilocybin

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy

Luoma JB

Europe PMC2020
ArticlePsilocybin

A Meta-Analysis of Placebo-Controlled Trials of Psychedelic-Assisted Therapy.

Luoma JB, Chwyl C, Bathje GJ +2

Europe PMC2020